Nasdaq Ewtx News Today

Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Get Free Report) CMO Joanne M. Donovan sold 3,682 shares of Edgewise Therapeutics stock in a transaction dated Thursday, May 2nd. The shares were sold at an average price of $18.91, for a total transaction of $69,626.62. Following the transaction, the chief marketing officer now directly owns 19,897 shares of […]

Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Get Free Report) CEO Kevin Koch sold 3,152 shares of the business’s stock in a transaction dated Thursday, May 2nd. The stock was sold at an average price of $18.91, for a total transaction of $59,604.32. Following the sale, the chief executive officer now directly owns 14,478 shares in the […]

Piper Sandler assumed coverage on shares of Edgewise Therapeutics (NASDAQ:EWTX – Free Report) in a research report report published on Thursday morning, Marketbeat Ratings reports. The brokerage issued an overweight rating and a $48.00 price target on the stock. Separately, Wedbush dropped their target price on Edgewise Therapeutics from $27.00 to $23.00 and set an […]

Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Get Free Report) insider Behrad Derakhshan sold 4,600 shares of the company’s stock in a transaction that occurred on Thursday, February 8th. The stock was sold at an average price of $20.01, for a total transaction of $92,046.00. Following the completion of the sale, the insider now directly owns 7,020 […]

Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Get Free Report) hit a new 52-week high on Thursday . The stock traded as high as $18.35 and last traded at $18.35, with a volume of 36720 shares trading hands. The stock had previously closed at $17.83. Analyst Ratings Changes Separately, Wedbush cut their target price on […]

Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Free Report) – Equities researchers at Wedbush lifted their FY2023 earnings per share (EPS) estimates for shares of Edgewise Therapeutics in a report issued on Monday, January 22nd. Wedbush analyst L. Chico now expects that the company will earn ($1.50) per share for the year, up from their prior forecast […]

Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Free Report) – Analysts at Wedbush issued their FY2028 earnings estimates for Edgewise Therapeutics in a research note issued to investors on Monday, January 22nd. Wedbush analyst L. Chico forecasts that the company will post earnings of $1.51 per share for the year. Wedbush currently has a “Outperform” rating and […]

Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Get Free Report) hit a new 52-week high during trading on Friday . The stock traded as high as $13.11 and last traded at $13.08, with a volume of 3033292 shares traded. The stock had previously closed at $9.69. Wall Street Analyst Weigh In Separately, Wedbush lowered their […]

Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Get Free Report) saw a significant growth in short interest in the month of December. As of December 15th, there was short interest totalling 8,500,000 shares, a growth of 20.9% from the November 30th total of 7,030,000 shares. Currently, 23.7% of the company’s shares are short sold. Based on an […]

Wedbush reiterated their outperform rating on shares of Edgewise Therapeutics (NASDAQ:EWTX – Free Report) in a research note issued to investors on Friday morning, Benzinga reports. Wedbush currently has a $27.00 price target on the stock. Other equities research analysts have also recently issued reports about the company. Truist Financial began coverage on Edgewise Therapeutics […]